KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Non Operating Income: 2009-2024

Historic Non Operating Income for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to -$373,000.

  • Pacira BioSciences' Non Operating Income rose 371.24% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.7 million, marking a year-over-year decrease of 129.84%. This contributed to the annual value of -$373,000 for FY2024, which is 100.54% down from last year.
  • As of FY2024, Pacira BioSciences' Non Operating Income stood at -$373,000, which was down 100.54% from -$186,000 recorded in FY2023.
  • Pacira BioSciences' Non Operating Income's 5-year high stood at -$186,000 during FY2023, with a 5-year trough of -$33.5 million in FY2021.
  • Its 3-year average for Non Operating Income is -$3.9 million, with a median of -$373,000 in 2024.
  • In the last 5 years, Pacira BioSciences' Non Operating Income skyrocketed by 98.35% in 2023 and then tumbled by 100.54% in 2024.
  • Pacira BioSciences' Non Operating Income (Yearly) stood at -$26.3 million in 2020, then fell by 27.64% to -$33.5 million in 2021, then surged by 66.32% to -$11.3 million in 2022, then surged by 98.35% to -$186,000 in 2023, then plummeted by 100.54% to -$373,000 in 2024.